Founded in 1999, genOway is a global biotechnology company providing highly predictive preclinical models and solutions to leading biopharmaceutical companies and academic institutions.
Based on its core business and cutting-edge expertise in highly predictive custom preclinical models, the company has developed its own catalog of translational models mainly focused on immuno-oncology and immunotherapy.
The company aims to provide unparalleled preclinical solutions to assess the success of a molecule in order to accelerate access to next-generation medicines for patients..